Blockade of Vascular Endothelial Growth Factor Receptor 1 Prevents Inflammation and Vascular Leakage in Diabetic Retinopathy

Diabetic retinopathy (DR) is a leading cause of blindness in working age adults. The objective of this study is to investigate the effects of vascular endothelial growth factor receptor 1 (VEGFR1) blockade on the complications of DR. Experimental models of diabetes were induced with streptozotocin (...

Full description

Saved in:
Bibliographic Details
Main Authors: Jianbo He, Hong Wang, Ying Liu, Wen Li, Dorothy Kim, Hu Huang
Format: Article
Language:English
Published: Wiley 2015-01-01
Series:Journal of Ophthalmology
Online Access:http://dx.doi.org/10.1155/2015/605946
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832548881295998976
author Jianbo He
Hong Wang
Ying Liu
Wen Li
Dorothy Kim
Hu Huang
author_facet Jianbo He
Hong Wang
Ying Liu
Wen Li
Dorothy Kim
Hu Huang
author_sort Jianbo He
collection DOAJ
description Diabetic retinopathy (DR) is a leading cause of blindness in working age adults. The objective of this study is to investigate the effects of vascular endothelial growth factor receptor 1 (VEGFR1) blockade on the complications of DR. Experimental models of diabetes were induced with streptozotocin (STZ) treatment or Insulin2 gene mutation (Akita) in mice. Protein expression and localization were examined by western blots (WB) and immunofluorescence (IF). mRNA expression was quantified by PCR array and real-time PCR. The activity of VEGFR1 signaling was blocked by a neutralizing antibody called MF1. Vascular leakage was evaluated by measuring the leakage of [3H]-mannitol tracer into the retina and the IF staining of albumin. VEGFR1 blockade significantly inhibited diabetes-related vascular leakage, leukocytes-endothelial cell (EC) adhesion (or retinal leukostasis), expression of intercellular adhesion molecule- (ICAM-) 1 protein, abnormal localization and degeneration of the tight junction protein zonula occludens- (ZO-) 1, and the cell adhesion protein vascular endothelial (VE) cadherin. In addition, VEGFR1 blockade interfered with the gene expression of 10 new cytokines and chemokines: cxcl10, il10, ccl8, il1f6, cxcl15, ccl4, il13, ccl6, casp1, and ccr5. These results suggest that VEGFR1 mediates complications of DR and targeting this signaling pathway represents a potential therapeutic strategy for the prevention and treatment of DR.
format Article
id doaj-art-4aaf3d0be3094be8a8a3d745f3034689
institution Kabale University
issn 2090-004X
2090-0058
language English
publishDate 2015-01-01
publisher Wiley
record_format Article
series Journal of Ophthalmology
spelling doaj-art-4aaf3d0be3094be8a8a3d745f30346892025-02-03T06:12:47ZengWileyJournal of Ophthalmology2090-004X2090-00582015-01-01201510.1155/2015/605946605946Blockade of Vascular Endothelial Growth Factor Receptor 1 Prevents Inflammation and Vascular Leakage in Diabetic RetinopathyJianbo He0Hong Wang1Ying Liu2Wen Li3Dorothy Kim4Hu Huang5Guangxi Tumor Hospital & Institute, Nanning, Guangxi 530021, ChinaDepartment of Ophthalmology, the Provincial Hospital Affiliated to Shandong University, Jinan, Shandong 250021, ChinaChangsha Aier Eye Hospital, Changsha, Hunan 410015, ChinaChangsha Aier Eye Hospital, Changsha, Hunan 410015, ChinaWilmer Eye Institute, Johns Hopkins University School of Medicine, M017 Robert H. and Clarice Smith Building, 400 N Broadway, Baltimore, MD 21287, USAWilmer Eye Institute, Johns Hopkins University School of Medicine, M017 Robert H. and Clarice Smith Building, 400 N Broadway, Baltimore, MD 21287, USADiabetic retinopathy (DR) is a leading cause of blindness in working age adults. The objective of this study is to investigate the effects of vascular endothelial growth factor receptor 1 (VEGFR1) blockade on the complications of DR. Experimental models of diabetes were induced with streptozotocin (STZ) treatment or Insulin2 gene mutation (Akita) in mice. Protein expression and localization were examined by western blots (WB) and immunofluorescence (IF). mRNA expression was quantified by PCR array and real-time PCR. The activity of VEGFR1 signaling was blocked by a neutralizing antibody called MF1. Vascular leakage was evaluated by measuring the leakage of [3H]-mannitol tracer into the retina and the IF staining of albumin. VEGFR1 blockade significantly inhibited diabetes-related vascular leakage, leukocytes-endothelial cell (EC) adhesion (or retinal leukostasis), expression of intercellular adhesion molecule- (ICAM-) 1 protein, abnormal localization and degeneration of the tight junction protein zonula occludens- (ZO-) 1, and the cell adhesion protein vascular endothelial (VE) cadherin. In addition, VEGFR1 blockade interfered with the gene expression of 10 new cytokines and chemokines: cxcl10, il10, ccl8, il1f6, cxcl15, ccl4, il13, ccl6, casp1, and ccr5. These results suggest that VEGFR1 mediates complications of DR and targeting this signaling pathway represents a potential therapeutic strategy for the prevention and treatment of DR.http://dx.doi.org/10.1155/2015/605946
spellingShingle Jianbo He
Hong Wang
Ying Liu
Wen Li
Dorothy Kim
Hu Huang
Blockade of Vascular Endothelial Growth Factor Receptor 1 Prevents Inflammation and Vascular Leakage in Diabetic Retinopathy
Journal of Ophthalmology
title Blockade of Vascular Endothelial Growth Factor Receptor 1 Prevents Inflammation and Vascular Leakage in Diabetic Retinopathy
title_full Blockade of Vascular Endothelial Growth Factor Receptor 1 Prevents Inflammation and Vascular Leakage in Diabetic Retinopathy
title_fullStr Blockade of Vascular Endothelial Growth Factor Receptor 1 Prevents Inflammation and Vascular Leakage in Diabetic Retinopathy
title_full_unstemmed Blockade of Vascular Endothelial Growth Factor Receptor 1 Prevents Inflammation and Vascular Leakage in Diabetic Retinopathy
title_short Blockade of Vascular Endothelial Growth Factor Receptor 1 Prevents Inflammation and Vascular Leakage in Diabetic Retinopathy
title_sort blockade of vascular endothelial growth factor receptor 1 prevents inflammation and vascular leakage in diabetic retinopathy
url http://dx.doi.org/10.1155/2015/605946
work_keys_str_mv AT jianbohe blockadeofvascularendothelialgrowthfactorreceptor1preventsinflammationandvascularleakageindiabeticretinopathy
AT hongwang blockadeofvascularendothelialgrowthfactorreceptor1preventsinflammationandvascularleakageindiabeticretinopathy
AT yingliu blockadeofvascularendothelialgrowthfactorreceptor1preventsinflammationandvascularleakageindiabeticretinopathy
AT wenli blockadeofvascularendothelialgrowthfactorreceptor1preventsinflammationandvascularleakageindiabeticretinopathy
AT dorothykim blockadeofvascularendothelialgrowthfactorreceptor1preventsinflammationandvascularleakageindiabeticretinopathy
AT huhuang blockadeofvascularendothelialgrowthfactorreceptor1preventsinflammationandvascularleakageindiabeticretinopathy